Table 2.
Additional comorbidities for patients included in this study
|
Comorbidity
|
Proportion of IIM patients without comorbidity
|
Proportion of control patients without comorbidity
|
P
value
|
| AIDS | 0.59% | 1.74% | 0.479 |
| Congestive heart failure | 29.66% | 30.68% | 1.000 |
| Depression | 37.3% | 40.52% | 0.402 |
| Diabetes mellitus1 | 44.35% | 58.61% | 0.000 |
| SUD–Drugs | 6.31% | 7.96% | 0.910 |
| SUD–Alcohol | 2.35% | 4.2% | 0.716 |
| Hypertension | 89.43% | 92.19% | 0.112 |
| Hypothyroidism | 42.44% | 38.21% | 0.059 |
| Liver disease | 12.92% | 12.45% | 0.355 |
| Lymphoma | 3.38% | 4.63% | 1.000 |
| Metastatic cancer | 5.14% | 6.8% | 0.901 |
| Neurological disease | 13.07% | 13.6% | 0.742 |
| Pulmonary disease1 | 45.96% | 55.86% | 0.001 |
| PVD1 | 30.1% | 30.54% | 0.008 |
1
Denotes significance, P < 0.05. Reported percentages reflect the proportion of total patients in each of the two sample populations (e.g., patients with idiopathic inflammatory myopathies or controls) with the listed comorbidity. AIDS: Acquired immunodeficiency syndrome; SUD: Substance use disorder; PVD: Peripheral vascular disease; IIM: Idiopathic inflammatory myopathies.